![H. Hogan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
H. Hogan
Direktor/Vorstandsmitglied bei
METACRINE, INC.
Profil
H.
Michael Hogan currently works at Otonomy, Inc., as Director from 2023 and Metacrine, Inc., as Director from 2023.
Mr. Hogan also formerly worked at Nabriva Therapeutics Plc, as Chief Executive Officer and Armanino LLP (United States), as Partner.
Mr. Hogan received his undergraduate degree from Colgate University.
Aktive Positionen von H. Hogan
| Unternehmen | Position | Beginn |
|---|---|---|
| METACRINE, INC. | Direktor/Vorstandsmitglied | 23.03.2023 |
| OTONOMY | Direktor/Vorstandsmitglied | 15.02.2023 |
Ehemalige bekannte Positionen von H. Hogan
| Unternehmen | Position | Ende |
|---|---|---|
Armanino LLP (United States)
 Armanino LLP (United States) Miscellaneous Commercial ServicesCommercial Services Operates as an accounting and consulting firm | Corporate Officer/Principal | - |
| NABRIVA THERAPEUTICS PLC | Vorstandsvorsitzender | - |
Ausbildung von H. Hogan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
20
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Colgate University
 Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Armanino LLP (United States)
Armanino LLP (United States) Miscellaneous Commercial ServicesCommercial Services Operates as an accounting and consulting firm | Commercial Services |
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurology diseases | Health Technology |
Metacrine, Inc.
 Metacrine, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in discovery and development of therapies for patients with liver and gastrointestinal diseases | Health Technology |
Nabriva Therapeutics Plc
 Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
